Business Context and Reporting Period
Company: Smith & Nephew plc (LSE: SN, NYSE: SNN)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: April 22, 2026
Reporting Period: First Quarter ended March 28, 2026
Business Overview: A global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company operates three global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It employs approximately 17,000 people and operates in over 100 countries.
Key Financial Metrics
Historical Context: The filing notes that the company generated annual sales of $6.2 billion in 2025.
Current Period Data: This filing is a trading report announcement and does not contain specific financial results for the first quarter of 2026. The following metrics are not provided in this document:
- Revenue for Q1 2026
- Profit or Trading Profit for Q1 2026
- Cash Flow
- Margins
- Debt and Liquidity positions
Material Changes
The filing does not provide comparative financial data or material changes versus the prior comparable period. It serves solely to announce the timing of the upcoming trading report.
Guidance, Outlook, and Risks
Upcoming Announcement: Smith & Nephew will announce its trading report for the first quarter ended March 28, 2026, on Wednesday, May 6, 2026, at 7:00 am BST / 2:00 am EDT. A conference call for financial analysts will follow at 8:30 am BST / 3:30 am EDT.
Forward-Looking Statements: The document includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ due to various risks.
Identified Risks:
- Conflicts in Europe and the Middle East.
- Economic and financial conditions affecting healthcare providers and payers.
- Price levels for medical devices and reimbursement decisions.
- Regulatory approvals, product defects, recalls, or quality management failures.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility and changes in taxation regulations.
- Competition for qualified personnel and integration risks from acquisitions.
Investor Verification Checklist
- Verify the specific Q1 2026 revenue and profit figures when the trading report is released on May 6, 2026.
- Confirm the impact of foreign exchange volatility on the reported results.
- Review the upcoming conference call for details on the product pipeline and market trends.
- Monitor any updates regarding regulatory approvals or reimbursement decisions mentioned in the risk factors.
- Check for any supply chain disruptions or geopolitical impacts on operations in Europe and the Middle East.